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Two national surveys of vision impairment and blindness were 
undertaken in The Gambia in 1986 and 1996. These provided data for 
the inception of The Gambia’s National Eye Health Programme (NEHP) 
within the Ministry of Health and Social Welfare. There have been 
important developments in the eye health services provided by the 
NEHP in the last 20 years. At the same time, the population has also 
undergone major demographic changes that may have led to 
substantial changes in the burden of eye disease. 
We conducted a National Eye Health Survey of vision impairment, 
blindness and its comorbidities in adults in The Gambia in 2019. We 
examined a nationally representative population-based sample of 
adults 35 years and above to permit direct comparison with the data 
available from the previous surveys. 
Alongside a comprehensive vision and eye examination, the survey 
provides nationally representative data on important comorbidities in 
this population: diabetes, hypertension, obesity, hearing impairment, 
disability and mental health. Secondly, it estimates access to assistive 
technologies and eye health services. Thirdly, it is powered to allow a 
five-year follow up cohort study to measure the incidence and 
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Introduction
National surveys of vision impairment (VI) and blindness 
were undertaken in The Gambia in 1986 and 19961,2. The 
1986 survey provided baseline data on the prevalence and 
causes of VI and blindness to support the inception of The 
Gambia’s National Eye Health Programme (NEHP) within the 
Ministry of Health and Social Welfare. The 1996 survey was 
completed on an independent sample using the same sampling 
and examination techniques to provide updated prevalence 
estimates and relative risk ratios compared to 1986.
The national all-age prevalence of blindness (presenting visual 
acuity [VA]<3/60, in the better seeing eye) was 0.7% in 1986 
and 0.4% in 1996 (confidence intervals [CI] not reported)1,2. 
The age-standardised difference between the estimates was 
not significant at the national level, but there was a higher rela-
tive risk of blindness in 1986 compared to 1996 (age adjusted 
risk ratio [adjRR] 2.2, 95% CI 1.2 – 3.8%) in the Western 
Region, where NEHP had first been instigated. Both sur-
veys categorised “low vision” as VA <6/18 and ≥3/60, and a 
modest increase in this category from 1.4% to 1.6% was 
observed nationally over the same period (adjRR 0.7, 0.6 – 0.9)2. 
Data on the prevalence of eye disease highlighted cataract, 
aphakia, uncorrected refractive errors and corneal infec-
tions as the leading causes of blindness and low vision in both 
studies1,2.
The 1996 survey also provided an opportunity to investi-
gate the burden of non-communicable diseases (NCDs) in The 
Gambia. The nationwide prevalence of being overweight and 
obese were 8.1% and 2.1% respectively, hypertension was 
24.2% and diabetes mellitus was 0.3%3.
In the more than twenty years since the last comprehensive 
eye health survey in The Gambia, the NEHP has developed fur-
ther. This has included the establishment of a new Regional 
Eye Care Centre in 2007 and several additional centres offer-
ing cataract surgery, distributed across the country. In addition, 
there has been major investment in the development of refrac-
tive error services and new in-country capacity to manufacture 
spectacles4.
During this same period The Gambia has undergone major 
demographic changes. The population has grown: from 800,000 
in 1986 to 1,170,000 in 1996 and 2,300,000 in 20181,2,5. Life 
expectancy has increased from 44 years in 1983 to 62 years 
in 2018, driving a relative and absolute increase in the propor-
tion of the population who are older and in whom prevalence of 
VI and blindness is highest6,7. There has also been considerable 
migration from rural to urban areas, with an associated change 
in lifestyle. Globally, increased urbanisation has been linked 
to increases in the prevalence of NCDs, particularly diabetes 
and hypertension8. Taken together, it is likely that the current 
population burden of eye disease in The Gambia differs sub-
stantially from previous estimates. To address this need for 
updated eye health data, we conducted a national survey of eye 
health and its comorbidities between February and July 2019.
Comprehensive eye health surveys are relatively resource inten-
sive in comparison to commonly used rapid methodologies, 
such as the Rapid Assessment of Avoidable Blindness (RAAB)9. 
RAAB uses simplified examination procedures and equipment 
and only samples the population 50 years and older (blindness 
prevalence is higher in this group than among all ages)10. RAAB 
provides a substantial proportion of Global Burden of Disease 
data on vision impairment and blindness11, but recent data com-
paring RAAB outputs to a more comprehensive methodology are 
lacking. As an additional objective, we nested the RAAB meth-
odology within this comprehensive survey methodology, to 
compare findings from a comprehensive versus rapid 
methodology on the same sample.
This protocol has been prepared to provide a detailed 
summary of the survey methods, sample characteristics and 




To assess the prevalence of vision impairment and its causes 
and comorbidities in a nationally representative population-
based sample of adults 35 years and older in The Gambia, 
and compare this with the situation in 1996.
Study objectives
1.    To estimate the prevalence and causes of vision impair-
ment and blindness in The Gambia in adults 35 years 
and older and 50 years and older, stratified by sex
2.    To estimate the prevalence of cataract, corneal blind-
ness/ocular trauma, uncorrected refractive error, trichi-
asis, glaucoma, diabetic retinopathy and age-related 
macular degeneration in the Gambia in adults 35 years 
and older and 50 years and older
3.    To evaluate the impact of current Gambia National 
Eye Health Programme activities, including the 
provision of cataract and refractive error services
4.    To estimate the prevalence of diabetes, hypertension 
and associated risk factors (body mass index, alco-
hol and tobacco) of NCDs in the Gambia in adults 
35 years and older, and relate these to ocular health
5.    To estimate the prevalence of hearing impairment, mus-
culoskeletal impairment, disability and mental health 
limitations in the Gambia in adults 35 years and older, 
and relate these to ocular health and the need for 
vision and hearing assistive products
6.    To establish a phenotyped baseline for a long-term 
eye health cohort study
7.    To compare outputs from a comprehensive eye health 
survey to a rapid methodology
Sample frame and size
The 2013 Gambia National Census population estimates were 
used as the sampling frame12. Multi-stage stratified cluster 
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random sampling with probability proportional to size proce-
dures were used to identify a nationally representative sample of 
adults 35 years and older, in clusters of 30. Clusters of 30 were 
selected as the pragmatic number of examinations each team 
could complete per day. These were selected from standard 
Gambia Bureau of Statistics (GBoS) Census Enumeration Areas 
(EAs). The country was divided into three broad regions for 
comparability to the 1996 estimates: Central, Eastern and 
Western (Figure 1). Each of these regions was further strati-
fied to reflect urban and rural population proportions, using 
Gambia Bureau of Statistics’ definitions.
The sample was powered to detect disease prevalence as low 
as 0.5% based on relevant literature on glaucoma, diabetic 
retinopathy and blindness prevalence in the region2,13,14. The 
calculation included a design effect of 2.5 to account for cluster 
sampling, assuming that samples would be moderately clus-
tered, with an intraclass correlation coefficient (ICC) of 0.038 
in clusters of approximately 30 adults 35 years and older15. 
Accounting for response/follow-up drop-out rate of 20%, 
regional and urban/rural stratification, and stratification by 
35 years and older and 50 years and older, the 5-year expected 
incidence rate of blindness, and a binomial exact distribution 
with an estimated margin of error of 0.25% to account for rare 
conditions (p<0.1), the overall sample size calculated was 10,800 
adults age 35 years and older in 360 clusters of approximately 
30 adults per cluster.
Team composition and training
Four teams collected the survey data. Each team was comprised 
of one ophthalmologist, one optometrist or optometry techni-
cian, one senior ophthalmic medical assistant (SOMA), one 
general nurse, one mental health nurse, and two enumerators. 
There is only one practicing audiology nurse in The Gambia, 
who joined one of the teams. This was sufficient given an 
expected prevalence of hearing impairment of 9%, requiring a 
sample size of 2,700 (1/4 the overall sample)16.
Teams underwent ten days of training in February 2019, 
including standardised tests of protocol adherence, practice 
examinations and pilot testing. Questionnaires were pre-tested, 
and revised where necessary following the pilot. A formal inter-
observer variability test was completed for vision testing. 
Compared to an arbitrarily selected gold standard, two teams 
achieved substantial agreement (0.7 and 0.8, both p<0.001), while 
one achieved fair agreement (0.4, p<0.001), requiring further 
consolidation of research protocol material before beginning data 
collection. Only two ophthalmologists were available for the 
entire duration of data collection. Two teams therefore included 
a number of different ophthalmologists over the course of 
the data collection, each trained by a predecessor during 
a minimum two-day handover.
Pre-data collection preparation
Data collection was scheduled to progress from the east to the 
west of the country, with all four teams travelling together and 
completing nearby clusters before moving to the next location. 
An advance team of enumerators moved ahead of survey teams 
to notify regional administrative stakeholders, sensitise com-
munities (both for cooperation and acceptance) and manage sur-
vey logistics. A vehicle maintenance and servicing schedule 
was prepared and regional fuel suppliers were identified. The 
Ministry of Health provided five 4-wheel drive vehicles for the 
study fieldwork, and released 24 clinical and 19 support staff 
from their roles, to participate in the survey. The Statistician 
General of GBoS released eight experienced survey field enu-
merators and a supervisor, and provided the study teams with 
EA and regional maps.
Data collection procedures
Participant recruitment and informed consent. Enumera-
tors used EA maps to visit each cluster in advance, complete 
a household listing of all eligible residents and identify a cen-
tral location for the examination. At each household, the pur-
pose of the survey was explained verbally to the household head 
or an adult key informant using a pre-written study participant 
information sheet (Extended data17).
If the household head or adult key informant agreed to partici-
pate, the enumerator recorded the age, sex and relationship to 
household head of all eligible household members, irrespective 
of availability.
Figure 1. Historic regions of the Gambia.
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Household members were eligible if they were 35 or older, 
residing in a household in the EA and:
•    Had lived in the house at least 6 months of the last year
•    Ate shared meals with other household members
•    Did not pay, and were not paid by, other household 
members
Once the listing was completed, enumerators segmented 
the list into groups of 30 participants, numbered these and 
selected one segment at random by drawing a number out of a 
hat. Enumerators returned to the selected segment to provide 
further information to household members about the details 
of examination at a central location (within the EA) the follow-
ing day, and to collect a Global Positioning System (GPS) point 
reading and data on household characteristics and indicators 
of socio-economic position (see below). Participants were 
given urine receptacles to fill the following morning and 
requested not to have breakfast until after the survey team had 
arrived.
Enrolment was completed the morning after enumeration, 
when enumerators returned to the household with the team’s 
general nurse. Written informed consent was collected by fin-
gerprint or signature for each available participant. Eligible 
participants who were not available after two repeat visits to the 
household were recorded as non-responders.
Data collection at the household. On the day of the exami-
nation, an enumerator and a general nurse first visited each 
household in the segment. Each participant was provided with 
a cardboard participant ID slip recording the household data 
collection outputs. This was used to track completion of 
each subsequent component of the examination protocol.
Participants first undertook a fasting Boehringer Mannheim glu-
cose test at their household, completed by the general nurse 
using sterile lancets, test strips and a glucometer (Accu-chek 
Aviva Meter). If the participant had not fasted (defined as 
only ingesting water in the last eight hours), the test was 
recorded as random. Our original protocol also included HbA
1c
 
testing using a portable HbA
1c
 machine (A1CNow+, Bayer) 
and finger blood sample for participants with fasting blood 
glucose >= 5.6mmol/L, random blood glucose >= 7.8 mmol/L, 
or a known history of diabetes. However, the ambient field 
work conditions (temperature and humidity) were such that 
the HbA
1c
 test performance was unreliable, and consequently 
this was abandoned.
Urinalysis was completed using Multistix 10 SF Urinalysis 
strips (Siemens). Tests for leucocytes, nitrates, proteins, blood, 
glucose, ketones and pH level were recorded on the partici-
pant slip. Participants were then invited to receive breakfast or 
lunch (staggered per 10 participants to avoid congestion at field 
stations) at the central location prior to the remainder of the 
survey assessment.
Data collection at the central location. Participant attend-
ance was recorded on entry at the central location, and data 
collected at the household was transferred from the partici-
pant ID slip to a mobile data collection form on a Huawei 
MediaPad M3 tablet device. Assessments were split across sev-
eral stations within the central location. The participant ID slip 
was used by team members to document assessment comple-
tion and relay information on referrals (see below). The full 
study questionnaire is available as Extended data17.
Demographics and general health assessment
The team general and mental health nurses completed the 
demographics and general health assessment.
Demographics and self-reported socio-economic position
A face photograph was taken of each participant to aid follow 
up, and demographic data including education, ethnic group and 
household composition was captured. EquityTool, an objec-
tive tool comprised of 12 country-specific assets, was used to 
generate a relative wealth index18. Three self-reported socio-
economic position tools were also used: perceived adequacy 
of household food consumption, perceived adequacy of 
household income and a socio-economic ladder question19.
Anthropometry
Height was measured using a Leicester height measure Mk II, 
with participant head positioned in the Frankfurt plane. Weight 
and body fat percentage were measured using a Tanita BC-545n 
body composition monitor.
Blood pressure
Blood pressure was measured in triplicate, once per arm and 
then repeated in the arm with the higher reading. The partici-
pant was seated, with their arm supported at the level of the 
heart and resting on a surface, and measured using an auto-
mated OMRON-Healthcare 10 Series blood pressure monitor 
(Omron). Measurements were taken five minutes apart, 
and an average of the last two measures was recorded for 
analysis.
Genetic sample
One upper cheek buccal swab sample was collected per par-
ticipant using a cyto-brush. Each specimen was sealed in 
an envelope labelled with the participant ID and stored at 
room-temperature.
Self-reported NCD history and risk factors
Participants responded to a pre-coded questionnaire module on 
personal and family history of diabetes, hypertension and cho-
lesterol level. Smoking and alcohol consumption habits were 
recorded and body image and attractiveness were assessed using 
the Figure Rating Scale20. Medication and treatment history 
were recorded for known diabetics and hypertensives.
Eye health assessment
Visual acuity was measured indoors by the team optometrist 
or optometry technician, with no direct sunlight or glare in 
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the direction of the participant or the VA test chart. The vision 
testing protocol is summarised diagrammatically in Extended 
data17.
Distance visual acuity: Monocular distance visual acuity (uncor-
rected and wearing available correction) was measured using 
Peek Acuity – a validated Android-deployed ‘tumbling E’ vis-
ual acuity test – on the tablet devices21. All participants whose 
uncorrected (or corrected, if wearing spectacles) visual acu-
ity was less than 6/12 in either eye underwent 1) a pinhole test 
in the eye(s) less than 6/12 (Lorgnette multi 17 occluder) and 
2) objective and subjective refraction of both eyes using a trial 
lens set and fixed wall chart (3 metre Snellen chart, Sussex 
Vision). Monocular best corrected visual acuity (BCVA) was 
measured with Peek Acuity following refraction.
Near vision screening: Binocular near vision screening was 
carried out with participants wearing near correction, if avail-
able (i.e. presenting near vision). A binary outcome of can (at 
least 4/5 optotypes correct), or cannot, read an N8 crowded tum-
bling E optotype at 40cm was recorded. If participants could not 
see N8 with presenting near vision they were corrected with 
age-appropriate near addition lenses in a trial frame and 
retested at the same threshold.
Contrast sensitivity: Monocular and binocular contrast sen-
sitivity was measured using the smartphone-based Peek 
Contrast test deployed on a Sony Z3 smartphone22. The test 
presented successively lower contrast tumbling E optotypes 
until they were no longer distinguishable from the background. 
The test provided a contrast sensitivity measure calibrated to 
the Pelli-Robson contrast sensitivity test, and an average 
measure of the ambient light in lux.
Intraocular pressure: Intraocular pressure (IOP) was measured 
by the team’s SOMA using an iCare ic100 tonometer accord-
ing to device specifications. Time of testing was recorded, and 
the first eye measured was alternated between participants to 
avoid operator bias. Unless contra-indicated by current cor-
neal infection, each iCare probe tip was disinfected and used 
six times before disposal23.
Ocular examination and imaging: The team’s ophthalmologist 
examined both eyes. First, the standard RAAB examination 
procedure was completed. This included undilated direct oph-
thalmoscopy examination of the anterior segment and fundus 
and a lens status screen with pen torch. The RAAB algorithm, 
whereby the most readily treatable condition only is recorded, 
was applied to categorise the main cause of VI (presenting 
<6/12) per eye and per person9. This was undertaken to allow 
the RAAB methodology-derived diagnosis of cause of VI 
to be compared with the findings of the subsequent detailed 
and dilated examination.
The eyelids and anterior segment of the eye (conjunctiva, 
sclera, cornea, iris and lens) were then examined in detail using 
a slit-lamp, to document presence of anterior segment eye 
disease and trachomatous trichiasis using a standard-
ised eye health survey examination form comparable to the 
1996 survey methodology. Table 1 describes the study’s out-
come measures, including where specific, published grad-
ing protocols for classifying particular eye diseases were 
followed.





Any Vision Impairment Presenting distance visual acuity (PVA, with available correction if worn) <6/12 in the 
better seeing eye
No Vision Impairment PVA ≥ 6/12 in the better seeing eye
Mild Vision Impairment PVA <6/12 and ≥ 6/18 in the better seeing eye
Moderate Vision 
Impairment
PVA <6/18 and ≥6/60 in the better seeing eye
Severe Vision Impairment PVA <6/60 and ≥3/60 in the better seeing eye
Blind PVA <3/60 in the better seeing eye
Sub-categories of 
blindness
Not blind PVA ≥ 3/60in the better seeing eye
<3/60 – 1/60 PVA <3/60 and ≥ 1/60 in the better seeing eye
<1/60 – Light Perception PVA ≥ 1/60 and light perception in the better seeing eye
No Light Perception No light perception in the better seeing eye
Low Vision (1996 
paper comparison)
Low Vision PVA <6/18 and ≥3/60 in the better seeing eye
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Presenting Near Vision 
Impairment
Cannot see N8 (binocular), with available correction if worn
Corrected Near Vision 
Impairment
Cannot see N8 (binocular), whilst wearing near correction
















Any Refractive Error Uncorrected visual acuity (UCVA) <6/12 improving to ≥ 6/12 with available correction, 
pinhole or refraction 
Vision Impairing 
Refractive Error
Presenting visual acuity (PVA) <6/12 improving to ≥ 6/12 with pinhole or refraction
Cataract24 Any grade 1 - 3 of nuclear, cortical or posterior capsular cataract or, if ungradable, any 
cataract marked mature or hypermature using WHO Cataract Grading Tool
Cataract Surgical 
Complications
Aphakia, posterior capsular opacification, aphakic bullous or pseudophakic bullous 
keratopathy identified on ophthalmic examination
Trachoma corneal 
opacity25,26
Current trichiasis (defined using WHO 2019 definition), or evidence of prior trichiasis 
surgery alongside corneal scarring (C2a – C4 only) in the same eye
Other corneal opacity26 Corneal scarring but no prior trichiasis or prior trichiasis surgery in the same eye (C2a 
– C4 only) 
Other anterior segment 
eye disease
Presence of at least one of the below pre-coded diseases, identified on slit lamp 
examination: pterygium (cornea involved), band keratopathy, corneal ulcer, uveitis, or 



















Any ARMD including: drusen or hypo/hyper pigmentation without degeneration, dry 
or geographic, or wet/neovascular or disciform
Glaucoma27 99.5% percentile of cup-disc ratio or asymmetry (Category 2), based on field grading. 
If optic disc not visible: PVA <3/60 and IOP in the 99.5% percentile
Any diabetic retinopathy28 Any diabetic retinopathy at least R1 or M1 using the Scottish Grading System, based 




Proliferative Retinopathy (R4) or Referable Maculopathy (M2) using the Scottish 
Grading System, based on dilated ocular photograph grading
Optic disc atrophy Optic disc atrophy marked as present but does not meet glaucoma definition
Other posterior segment 
eye disease
Presence of pseudo-exfoliation, identified on slit lamp examination or other posterior 
segment disease described in open text
Main cause of distance 
vision impairment
In all eyes with PVA<6/12, disease presence as above. 
If more than one of the above definitions are met in one eye using the definitions 
above, the main cause will be listed as the highest ranking in order of: 
  1.  Refractive Error 
  2.  Cataract 
  3.  Other Anterior Segment 
  4.  Posterior segment 
  5.  Globe 
  6.  Unknown 
If more than one of the above definitions is met in one person, the main cause at 
the person level will be listed as the highest ranking in this order. Participants with 
PVA<6/12 with no reported anterior or posterior segment disease as defined above 
were categorised as unknown. 
A known limitation of this hierarchical approach to determining the “main cause” is 
that it will lead to under estimation of posterior segment causes. The proportion of 
people with comorbidities will be reported, and manuscripts detailing prevalence 
and associations of specific eye diseases will provide further detailed breakdown on 
anterior and posterior causes of VI.
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Unless contra-indicated (IOP ≥35mmHg or van Herrick’s 
grade 2 or 1 was recorded), all participants were then dilated in 
both eyes using the short-acting mydriatic eye drop tropica-
mide 1%. A slit lamp and a 90D fundus lens, were used to com-
plete a comprehensive examination and grade predetermined 
lens, retinal and optic disc disease.
Imaging was completed by the team’s SOMA. The anterior 
segment of both eyes was photographed using a Nikon D5600 
Digital Single Lens Reflex (SLR) camera with macro lens and 
flash. The posterior segment was photographed (disc centred 




Secondary Outcome Measures (non-ocular)
Hypertension Average systolic blood pressure values across two readings of ≥140 mmHg and/or 
diastolic values of ≥90 mmHg and/or taking antihypertensive medication and/or 
reported history of hypertension
Diabetes Diabetic Reported history of diabetes (told by healthcare worker and/or on diabetic treatment), 
fasting blood glucose (FBG) ≥7mmol/L or random blood glucose (RGB) ≥11mmol/L
Pre-diabetic FBG >5.6 <7, or RBG ≥7.8 <11
Not diabetic No reported history of diabetes and neither impaired FBG or RBG
Obesity Underweight Body Mass Index (BMI) under 18
Normal BMI ≥18 and <25




None >19 decibels hearing level (dbHL) jn either ear
Mild 20 to <35 dBHL in the better hearing ear
Moderate 35 to <50 dBHL in the better hearing ear
Moderately Severe 50 to <65 dBHL in the better hearing ear
Severe 65 to <0 dBHL in the better hearing ear
Profound 80 to <95 dBHL in the better hearing ear
Complete/ total 95 dBHL or greater in the better hearing ear
Binary Classification 20dbHL or greater in the better hearing ear
Anxiety31 None Score of 0-4 on GAD-7
Mild Score of 5-9 on GAD-7
Moderate Score of 10-14 on GAD-7
Severe Score of ≥15- on GAD-7
Binary Classification Score of ≥ 10 on GAD-7
Depression32 None Score of 0-4 on PHQ-9
Mild Score of 5-9 on PHQ-9
Moderate Score of 10-14 on PHQ-9
Moderately Severe Score of 15-19 on PHQ-9
Severe Score of 20-27 on PHQ-9
Binary Classification Score of ≥ 10 on PHQ-9
Disability Any of the 6 Washington Group Short Set Functional Domains reported “a lot of 
difficulty” or “cannot do”
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Other impairment and functioning assessment
Self-reported functioning: The team general nurse used the 
Washington Group Short Set to measure self-reported functional 
limitations in seeing, hearing, walking/climbing, remembering/
concentrating, understanding/being understood and selfcare34. 
Mental Health was assessed by the mental health nurse using 
two well-established tools: The Patient Health Questionnaire 9 
(PHQ 9) for measuring depression35, and the Generalised Anxiety 
Disorder 7 item tool (GAD-7)36, for anxiety.
Self-reported assistive product use and need: The general nurse 
asked reported need for, use of and barriers to access to assisted 
products (including glasses) using a modified version of the 
World Health Organisation (WHO) rapid assistive technology 
assessment (rATA)37.
Musculoskeletal impairment: The general nurse used the six 
screening questions from the Rapid Assessment of Muscu-
loskeletal impairment to screen for musculoskeletal impairment 
(MSI)38.
Hearing impairment: In the team measuring hearing impair-
ment, an audiology nurse screened for hearing impairment using 
HearTest, a validated mobile pure tone audiometry applica-
tion deployed on a Samsung Galaxy A3 Smartphone together 
with calibrated, noise-cancelling Sennheiser HD280 pro circu-
maural headphones39. Hearing tests were completed in a separate 
and private area, and ambient noise levels were automatically 
recorded by the device, which flagged a warning when these 
reached unacceptable levels. Following the Rapid Assessment 
of Hearing Loss (RAHL) methodology, all participants screened 
for hearing impairment also had their ears briefly examined 
by the team audiology nurse to assess ear health, and if appli-
cable determine cause of hearing loss and appropriate referral 
mechanisms16.
Diagnoses and referrals
Survey teams carried basic first aid kits and medicines for treat-
ing common illnesses, and referral letters for onward services. 
Referrals for eye conditions were made to the Sheikh Zayed 
Regional Eye Care Centre in Kanifing, close to the capital 
city Banjul. Participants with blood pressure readings above 
95 mm/Hg diastolic or 150 mm/Hg systolic, alongside 
participants judged by the team general nurse to require fol-
low up services for other reasons (including emergencies) were 
referred to relevant primary health services. The team mental 
health nurses made referrals to relevant mental health serv-
ices as per their clinical judgement following screening. Any 
participant with hearing impairment ≥35 dBA in the better ear 
or who was otherwise considered in need of referral by the 
audiology nurse was referred to the relevant ENT services.
Data management
Data collection forms were built using Open Data Kit (ODK) 
software40. Tablets were password protected and team leaders 
used data SIM cards to transfer the encrypted data to a secure 
ODK server held at the London School of Hygiene & Tropical 
Medicine (LSHTM) daily. Electronic data support was 
provided by LSHTM Global Health Analytics (odk.lshtm.
ac.uk). During data collection, anterior segment images were 
stored locally on password-protected laptop computers and 
backed up weekly to password-protected storage drives. After 
data collection, all images were transferred to a secured LSHTM 
server.
Anonymised posterior segment images were transferred via 
WiFi daily to a secured cloud-based platform. Fundus image 
grading for diabetes, AMD and glaucoma will be performed 
remotely by trained ophthalmologists, following a formal training 
and inter-observer variation test.
Data preparation
Data collection was completed between March and July 
2019. Raw data were exported from the secure server and 
imported into STATA version 14.0. Data were merged into a 
single database and anonymised.
Data completeness. To prevent listwise deletion, all data were 
checked for completeness. Figure 2 summarises this process.
Sample characteristics. Table 2 presents the final sample pop-
ulation characteristics, compared with the characteristics of 
the population in the 2013 Census12. The survey oversampled 
women compared to men (70.3% female vs. 29.7% male). 
Additionally, selection probabilities were lower than expected 
in several age groups (5-year band) and in clusters.
Poststratification sample weights were calculated to account 
for the disproportionate age-sex sampling by 5-year band. 
Two sample weights were created, one to generalize the find-
ings to the 2013 Gambia Census12, and one to the WHO Stand-
ard Population41. All weights were then multiplied with the 
cluster selection probabilities.
Defining outcome measures. Table 1 describes the definitions 
for the study’s primary and secondary outcome measures.
Socio-economic position imputation. Quintiles based on the 
Gambia Demographic and Health Survey 2013 were estab-
lished following EquityTool procedures. To improve the integ-
rity of socioeconomic position (SEP) data, all 12 EquityTool 
questions were checked for completeness. Preliminary analy-
sis revealed that among all 360 clusters, 67 had at least one 
participant with one or more questions unanswered. Missing 
data were handled by re-approaching non-respondents of 23 
clusters where more than half of its participants had incomplete 
SEP data.
For the remaining observations missing data, mean imputation 
was used in which the most frequent value of a cluster filled the 
missing attribute’s value. Each of the EquityTool questions was 
treated independently of other questions and of other clusters. 
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Table 2. Sample characteristics.
Sample, n (%) Census 2013, n (%)
Age Group
35 – 44 4,102 (44.7) 167,595 (43.7)
45 – 54 2,061 (22.4) 101,183 (26.4)
55 – 64 1,444 (15.7) 56,894 (14.8)
65 – 74 1,018(11.1) 33,755 (8.8)
75 – 84 441 (4.8) 16,521 (4.3)
85+ 122 (1.3) 7779 (2.0)
Mean (SD) 49.6 (13.4)
Sex
Male 2,710 (29.5) 192,969 (50.3)
Female 6,478 (70.5) 190,758 (49.7)
Region
Central 1,476 (16.1) 301,122 (16.2)
East 2,087 (22.7) 459,127 (24.7)
West 5,625 (61.2) 1,096,932 (59.1)
Location
Rural 4,149 (45.2) 783,884 (42.2)
Urban 5,039 (54.8) 1,073,297 (57.8)
Figure 2. Flow chart of data completeness.
Sample, n (%) Census 2013, n (%)
Ethnicity
Mandinka/Jahanka 3,564 (38.8) 120,000 (34.9%)
Wollof 1,365 (14.9) 50,494 (14.7%)
Jola/Karoninka 1,079 (11.7) 41,820 (12.1%)
Fula/Tukulur/ 
Lorobo
1,847 (20.1) 76,753 (22.3%)
Serere 287 (3.1) 11,570 (3.4%)
Serahuleh 677 (7.4) 25,442 (7.4%)
Creole and 
AkuMarabo
22 (0.2) 2,570 (0.7%)
Manjago 171 (1.9) 7,095 (2.1%)
Bambara 69 (0.8) 3,822 (1.1%)
Other ethnic group 103 (1.1) 4,653 (1.3%)
Non-Gambian 4 (0.0)
SEP quintile




5th (Richest) 2,650 (28.8)
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Missing values were not substituted if there was more than a 
single most frequent response observed for that attribute.
Ethics
Ethical approval for the study was granted in 2019 by the 
Gambia Government/MRC Joint Ethics Scientific Coordinating 
Committee (SCC, Ref 1635) and the LSHTM Observational/ 
Interventions Ethics Committee (Ref 16172).
Dissemination, engagement and data availability
A summary of survey findings will be shared with relevant 
stakeholders through the Directorate of Planning and Infor-
mation (DPI) of the Ministry of Health. Study results will be 
published in a suite of peer-reviewed manuscripts later in 2021 
and beyond. The study team includes the National Eye Health 
Coordinator in the Gambia (AH), ensuring that results will 
feed directly into population eye health service planning. The 
anonymised dataset will be made available on reasonable request 
from the study team.
Study status
Data has been collected and prepared for analysis. Data analysis 
is ongoing across different study objective areas.
Strengths and limitations
The data from the Gambia National Eye Health Survey 2019 
will provide valuable, robust data on population eye health and 
comorbidities in a nationally representative sample of the popu-
lation of the Gambia 35 years and older. We used validated 
tools and collected data in line with international priorities 
and the Universal Health Coverage agenda. The inclusion of 
modules on disability, hearing, musculoskeletal impairment, 
mental health and NCDs will support evidence-based service 
provision and greater understanding of comorbidities. The 
phenotyping and sample adjustment to support establishment 
of a cohort study may provide powerful data on the incidence 
and progression of disease. There were also limitations. The 
comprehensive nature of the protocol led to higher than expected 
incomplete examinations and non-response rates, requiring 
sampling weights to be applied. The 2019 survey fieldwork 
did not include visual fields testing unlike the 1996 survey that 
used the Henson Visual Fields Analyzer. While we took advan-
tage of newer hand-held techniques where appropriate, it was 
logistically challenging to set up central locations in each cluster 
without electricity to power table-top/table-mounted equip-
ment, quiet areas for hearing testing and a food preparation area 
for participant lunches; all of which contributed to occasional 
delays for participants. Further, conditions did not allow us to 
proceed with HbA
1c
 testing, and human resource constraints did 
not permit continuity of examiners, potentially leading to meas-
urement bias. Two teams had high turnover of ophthalmologists 
at various stages of the data collection. These human resource 
challenges meant some clusters had to be revisited in order to 
examine 80% or more listed participants.
The period April to July in The Gambia coincides with the 
pre-rainy and rainy/farming season, which sees most rural 
Gambian men 35 years and older spending more time in their 
farms. This social pattern skewed the population that was 
available on the morning of examination towards females.
Conclusion
The Gambia National Eye Health Survey 2019 will provide data 
to support eye health and broader health service planning in The 
Gambia and allow critical appraisal of changes in the popula-
tion’s eye health needs in comparison to earlier national surveys 
of 1986 and 1996. This survey shall provide a basis to explore 
the broader understanding of the evolution of chronic and blind-
ing eye diseases and other co-morbid health conditions in a 
rapidly increasing West African population.
Data availability
Underlying data
No data were associated with this article.
Extended data
Open Science Framework: Gambia National Eye Health 
Survey 2019 Study Documents, https://doi.org/10.17605/OSF.IO/
EKCDT17.
This project contains the following extended data:
-    Study questionnaire
-    Informed consent sheet
-    Vision testing protocol
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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